Ironwood Pharmaceuticals Inc (IRWD) — Cash Flow Quality Index
Ironwood Pharmaceuticals Inc (IRWD) has a Cash Flow Quality Index of 0.13x as of March 2026. Operating cash flow of $5.12 Million is below net income of $40.77 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore IRWD cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ironwood Pharmaceuticals Inc Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Ironwood Pharmaceuticals Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Ironwood Pharmaceuticals Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Ironwood Pharmaceuticals Inc (2019–2025)
Year-by-year earnings quality comparison for Ironwood Pharmaceuticals Inc. For live market cap and the full company financial profile, see market value of Ironwood Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 5.29x | $127.04 Million | $24.02 Million | ▼ -95.5% |
| 2024 | 117.67x | $103.55 Million | $880.00K | ▲ +7424.7% |
| 2022 | 1.56x | $273.76 Million | $175.06 Million | ▲ +215.5% |
| 2021 | 0.50x | $261.89 Million | $528.45 Million | ▼ -68.8% |
| 2020 | 1.59x | $168.84 Million | $106.18 Million | ▲ +218.8% |
| 2019 | 0.50x | $10.72 Million | $21.50 Million | — |